Cargando…

Prognostic value of copeptin in patients with acute myocardial infarction treated with percutaneous coronary intervention: a prospective cohort study

BACKGROUND: Ischemic myocardial injury leads to neurohormonal system activation and increased release of copeptin. Although diagnostic value of copeptin has been widely described, data on its prognostic performance in patients with myocardial infarction is inconclusive. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roczek-Janowska, Marta, Kacprzak, Michal, Dzieciol, Malgorzata, Zielinska, Marzenna, Chizynski, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339760/ https://www.ncbi.nlm.nih.gov/pubmed/34422339 http://dx.doi.org/10.21037/jtd-21-359

Ejemplares similares

Atrial Natriuretic Peptides, Right Atrial Infarction and Prognosis of Patients with Myocardial Infarction—A Single-Center Study
por: Kacprzak, Michal, et al.
Publicado: (2021)

Shock index and TIMI risk index as valuable prognostic tools in patients with acute coronary syndrome complicated by cardiogenic shock
por: Supeł, Karolina, et al.
Publicado: (2020)

Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis
por: Salska, Agata, et al.
Publicado: (2018)

Acute coronary syndrome versus acute myocarditis in young adults–value of speckle tracking echocardiography
por: Wieczorkiewicz, Paulina, et al.
Publicado: (2022)

Copeptin—Marker of Acute Myocardial Infarction
por: Möckel, Martin, et al.
Publicado: (2014)

Serum Copeptin Levels Predict Clinical Outcomes After Successful Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
por: Choi, Hyun-Jung, et al.
Publicado: (2018)

Soluble urokinase plasminogen activator receptor in one-year prediction of major adverse cardiac events in patients after first myocardial infarction treated with primary percutaneous coronary intervention
por: Wlazeł, Rafał N., et al.
Publicado: (2016)

Platelets miRNA as a Prediction Marker of Thrombotic Episodes
por: Bijak, Michal, et al.
Publicado: (2016)

Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor
por: Pintado, María-Consuelo, et al.
Publicado: (2022)

Copeptin Testing in Acute Myocardial Infarction: Ready for Routine Use?
por: Reinstadler, Sebastian Johannes, et al.
Publicado: (2015)

Variations in Blood Platelet Proteome and Transcriptome Revealed Altered Expression of Transgelin-2 in Acute Coronary Syndrome Patients
por: Szelenberger, Rafał, et al.
Publicado: (2022)

The prognostic value of copeptin for acute intracerebral hemorrhage patients
por: ZHANG, AIMEI, et al.
Publicado: (2013)

Prognostic value of copeptin in patients with acute ischemic stroke
por: Tu, Wen-Jun, et al.
Publicado: (2011)

Prognostic value of copeptin in patients with acute coronary syndrome: A systematic review and meta-analysis
por: Lu, Jiapeng, et al.
Publicado: (2020)

The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively
por: Mazurek, Michal, et al.
Publicado: (2012)

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Zhao, Li-Hong, et al.
Publicado: (2022)

Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
por: Zampino, Rosa, et al.
Publicado: (2021)

Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction
por: Gu, Youlan L., et al.
Publicado: (2011)

Performance of Copeptin for Early Diagnosis of Acute Myocardial Infarction in an Emergency Department Setting
por: Jeong, Ji Hun, et al.
Publicado: (2020)

Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
por: Nogami, Kai, et al.
Publicado: (2022)

Remote Ischemic Preconditioning and Contrast-Induced Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial
por: Stokfisz, Karolina, et al.
Publicado: (2020)

Dysregulation in the Expression of Platelet Surface Receptors in Acute Coronary Syndrome Patients—Emphasis on P2Y12
por: Szelenberger, Rafał, et al.
Publicado: (2022)

Prognostic Value of Eosinophil to Leukocyte Ratio in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Konishi, Takao, et al.
Publicado: (2017)

Screening Analysis of Platelet miRNA Profile Revealed miR-142-3p as a Potential Biomarker in Modeling the Risk of Acute Coronary Syndrome
por: Szelenberger, Rafał, et al.
Publicado: (2021)

Prognostic Value of Left Atrium Remodeling after Primary Percutaneous Coronary Intervention in Patients with ST Elevation Acute Myocardial Infarction
por: Cho, Jang Hyun, et al.
Publicado: (2012)

Prognostic Value of Pentraxin-3 Change After Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction
por: Li, Sheng-Yu, et al.
Publicado: (2023)

Prognostic Analysis for Cardiogenic Shock in Patients with Acute Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Lin, Mao-Jen, et al.
Publicado: (2017)

Prognostic Impact of Percutaneous Coronary Intervention of Chronic Total Occlusion in Acute and Periprocedural Myocardial Infarction
por: Kim, Seung-Hyun, et al.
Publicado: (2021)

Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022)

Risk Factors of Suboptimal Coronary Blood Flow after a Percutaneous Coronary Intervention in Patients with Acute Anterior Wall Myocardial Infarction
por: Maruszak, Natalia, et al.
Publicado: (2023)

Prognostic value of frontal QRS-T angle in predicting survival after primary percutaneous coronary revascularization/coronary artery bypass grafting for ST-elevation myocardial infarction
por: Sawant, Abhishek C., et al.
Publicado: (2019)

Copeptin levels in patients with coronary artery ectasia
por: Yavcin, Ozkan, et al.
Publicado: (2019)

Clinical outcomes in patients with acute myocardial infarction treated with primary percutaneous coronary intervention stratified according to duration of pain-to-balloon time and type of myocardial infarction
por: Staszczak, Bartłomiej, et al.
Publicado: (2023)

Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome
por: Morawiec, Beata, et al.
Publicado: (2018)

Percutaneous coronary intervention for acute myocardial infarction with mitral regurgitation
por: Tu, Yan, et al.
Publicado: (2016)

Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model
por: Boeckel, Jes-Niels, et al.
Publicado: (2016)

Accelerated Rule-Out of acute Myocardial Infarction using prehospital copeptin and in-hospital troponin: The AROMI study
por: Pedersen, Claus Kjær, et al.
Publicado: (2023)

Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: SÖĞÜT, Özgür, et al.
Publicado: (2021)

Prognostic value of the prognostic nutritional index for patients with acute myocardial infarction undergoing percutaneous coronary intervention with variable glucose metabolism statuses: a retrospective cohort study
por: Ling, Xuebin, et al.
Publicado: (2023)

Transradial percutaneous coronary intervention for unprotected left main closure during acute myocardial infarction
por: Chyrchel, Michał, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vn56ggqo6cvrh0223592ag530h